Fund Holdings — Kynam Capital Management, LP

Total Portfolio Value:
$1.17B
Total Bought:
$190.59M
Total Sold:
$258.69M
Net Transaction:
-$68.11M
Notable People:
Kynam Capital Management Gp,
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Natera, Inc.(NTRA)2,022,0981,167,570-854,528$320.10M$165.11M14.13%-$154.99M
Vaxcyte, Inc.(PCVX)2,336,7963,200,000+863,204$191.29M$120.83M10.34%-$70.46M
Celldex Therapeutics, Inc.(CLDX)5,064,2076,500,000+1,435,793$127.97M$117.97M10.09%-$10.00M
Syndax Pharmaceuticals, Inc.(SNDX)8,520,0008,520,0000$112.63M$104.67M8.96%-$7.97M
BioCryst Pharmaceuticals, Inc.(BCRX)9,085,3688,928,523-156,845$68.32M$66.96M5.73%-$1.36M
CG Oncology, Inc.(CGON)2,519,7052,611,662+91,957$72.27M$63.96M5.47%-$8.31M
Viridian Therapeutics, Inc.(VRDN)3,326,2624,700,000+1,373,738$63.76M$63.36M5.42%-$408.4K
Vera Therapeutics, Inc.CL A(VERA)1,457,9102,400,000+942,090$61.66M$57.65M4.93%-$4.01M
Cogent Biosciences, Inc.(COGT)9,105,0009,105,0000$71.02M$54.54M4.67%-$16.48M
Immunocore Holdings plcADS(IMCR)1,225,5761,695,576+470,000$36.15M$50.31M4.30%+$14.15M
Beam Therapeutics Inc.(BEAM)1,756,1582,518,170+762,012$43.55M$49.18M4.21%+$5.63M
Wave Life Sciences, Inc.SHS(WVE)4,899,4974,899,4970$60.61M$39.59M3.39%-$21.02M
Dynavax Technologies Corp6,560,8352,620,797-3,940,038$83.78M$33.99M2.91%-$49.79M
Travere Therapeutics, Inc.(TVTX)1,802,7501,802,7500$31.40M$32.31M2.76%+$901.4K
Tyra Biosciences, Inc.(TYRA)530,4782,406,067+1,875,589$7.37M$22.38M1.91%+$15.00M
Engene Holdings Inc
COM
4,994,0904,994,0900$33.21M$22.37M1.91%-$10.84M
Legend Biotech CorporationADS(LEGN)0610,000+610,000$0$20.70M1.77%+$20.70M
Cullinan Therapeutics, Inc.(CGEM)1,252,7382,338,629+1,085,891$15.26M$17.70M1.51%+$2.45M
Nurix Therapeutics, Inc.(NRIX)0800,000+800,000$0$9.50M0.81%+$9.50M
Liquidia Corporation(LQDA)2,266,328633,802-1,632,526$26.65M$9.35M0.80%-$17.30M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)4,685,5635,822,938+1,137,375$20.76M$8.56M0.73%-$12.20M
Relay Therapeutics, Inc.(RLAY)1,000,0003,063,292+2,063,292$4.12M$8.03M0.69%+$3.91M
Geron Corporation(GERN)03,659,526+3,659,526$0$5.82M0.50%+$5.82M
Amarin Corp PlcADR12,414,62812,414,6280$6.02M$5.56M0.48%-$458.1K
Burning Rock Biotech LimitedADS(BNR)994,883994,8830$6.72M$4.38M0.37%-$2.34M
Sutro Biopharma, Inc.(STRO)3,641,4475,441,447+1,800,000$6.70M$3.54M0.30%-$3.16M
Design Therapeutics, Inc.(DSGN)0904,017+904,017$0$3.49M0.30%+$3.49M
Caribou Biosciences, Inc.(CRBU)2,406,1473,269,147+863,000$3.83M$2.99M0.26%-$840.7K
Proqr Thrapeutics N VSHS EURO
SHS EURO
1,750,0001,750,0000$4.64M$2.33M0.20%-$2.31M
Climb Bio, Inc.(CLYM)547,0001,047,000+500,000$984.6K$1.28M0.11%+$292.7K
UroGen Pharma Ltd.(URGN)025,000+25,000$0$276.5K0.02%+$276.5K
2seventy Bio Inc5,953,8250-5,953,825$17.50M$0—-$17.50M
Acelyrin Inc847,3660-847,366$2.66M$0—-$2.66M
Protagonist Therapeutics Inc390,7920-390,792$15.08M$0—-$15.08M
Page 1 of 1
Kynam Capital Management, LP — 13F Holdings — Q1 2025 | TickerTrail